| Jumlah Saham Beredar | 112,873,552 shares |
| Saham Orang Dalam | 161,383,910 shares |
| Orang Dalam Sejati | 17 |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
0 ( )
8925 out of 11305Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
0.000 %( )
8841 out of 11224Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan Vaxxinity, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
| Gregory R Blatt Director - [D] | 76,923 | 76,923 | |
| James Chui Director - [D] | 14,000 | 14,000 | |
| Peter Diamandis Director - [D] | 2,019,880 | 2,019,880 | |
| Martin Doran See Remarks - [O] | 22,688 | 22,688 | |
| Farshad Guirakhoo (Former) Chief Scientific Off. - [O] | 68,645 | 68,645 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
| George R Hornig | 67,953 | ||
|
Mei Mei Hu
See Remarks, Director, 10% Owner -
[D]
[O]
|
51,737,344 | 51,737,344 | |
| Landon E Ogilvie Director - [D] | 32,850 | 32,850 | |
| Ulo Palm Chief Medical Officer - [O] | 450 | 450 | |
| Molina Rene Paula | 96,153 | ||
| Jason Pesile | 51,225 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
| Peter Powchik Director - [D] | 225,858 | 225,858 | |
|
Prime Movers Lab Fund I LP
10% Owner -
|
3,594,122 | 3,594,122 | |
|
Lou Reese
Executive Chairman, Director, 10% Owner -
[D]
[O]
|
51,737,344 | 51,737,344 | |
|
Dakin Sloss
10% Owner -
|
9,738,192 | 3,594,122 | |
| James Alan Smith Director - [D] | 116,462 | 116,462 | |
|
United Biomedical Inc
10% Owner -
|
51,737,344 | 51,737,344 |
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di VAXX / Vaxxinity, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di VAXX / Vaxxinity, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
| Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-08 | 2023-09-08 | 4 | Prime Movers Lab Fund I LP Held by Prime Movers Growth Fund 1 LP | VAXX | Class A common stock | I | 1.6700 | -10,349 | -17 | 3,594,122 | ||||
| 2023-09-08 | 2023-09-08 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A common stock | I | 1.6700 | -4,217 | -7 | 1,464,578 | ||||
| 2023-09-08 | 2023-09-08 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 1.6700 | -2,395 | -4 | 831,658 | ||||
| 2023-09-08 | 2023-09-08 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A common stock | D | 1.6700 | -25,089 | -42 | 8,713,663 | ||||
| 2023-09-08 | 2023-09-08 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A common stock | I | 1.6700 | -5,911 | -10 | 2,053,079 | ||||
| 2023-09-08 | 2023-09-07 | 4 | Prime Movers Lab Fund I LP Held by Prime Movers Growth Fund 1 LP | VAXX | Class A common stock | I | 1.7872 | -8,378 | -15 | 3,604,471 | ||||
| 2023-09-08 | 2023-09-07 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A common stock | I | 1.7872 | -3,413 | -6 | 1,468,795 | ||||
| 2023-09-08 | 2023-09-07 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 1.7872 | -1,939 | -3 | 834,053 | ||||
| 2023-09-08 | 2023-09-07 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 1.7872 | -20,312 | -36 | 8,738,752 | ||||
| 2023-09-08 | 2023-09-07 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 1.7872 | -4,786 | -9 | 2,058,990 | ||||
| 2023-09-08 | 2023-09-06 | 4 | Prime Movers Lab Fund I LP Held by Prime Movers Growth Fund 1 LP | VAXX | Class A Common Stock | I | 1.8823 | -2,189 | -4 | 3,612,849 | ||||
| 2023-09-08 | 2023-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 1.8823 | -892 | -2 | 1,472,208 | ||||
| 2023-09-08 | 2023-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 1.8823 | -507 | -1 | 835,992 | ||||
| 2023-09-08 | 2023-09-06 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 1.8823 | -5,308 | -10 | 8,759,064 | ||||
| 2023-09-08 | 2023-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 1.8823 | -1,251 | -2 | 2,063,776 | ||||
| 2023-05-02 | 2023-04-26 | 4 | Diamandis Peter | VAXX | Class A common stock | D | 1.2100 | 46,500 | 56 | 906,141 | ||||
| 2023-05-02 | 2023-04-26 | 4 | Diamandis Peter | VAXX | Class A common stock | D | 0.5700 | 429,037 | 245 | 859,641 | ||||
| 2023-04-28 | 3/A | Smith James Alan By IO Fund, LLC | VAXX | Class A common stock | I | 54,202 | ||||||||
| 2023-04-28 | 3/A | Smith James Alan | VAXX | Class A common stock | D | 8,058 | ||||||||
| 2023-02-10 | 3 | Smith James Alan | VAXX | Class A common stock | D | 8,058 | ||||||||
| 2023-02-10 | 3 | Smith James Alan By IO Fund, LLC | VAXX | Class A common stock | I | 12,268 | ||||||||
| 2023-02-10 | 3 | Ogilvie Landon E By child | VAXX | Class A common stock | I | 32,850 | ||||||||
| 2023-01-25 | 2023-01-23 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A common stock | D | 3.3514 | -405,217 | -1,358 | 8,764,372 | ||||
| 2023-01-25 | 2023-01-23 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A common stock | I | 3.3514 | -95,475 | -320 | 2,065,027 | ||||
| 2022-12-05 | 2022-12-02 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2.5682 | -11,121 | -29 | 9,169,589 | ||||
| 2022-12-05 | 2022-12-02 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2.5682 | -2,620 | -7 | 2,160,502 | ||||
| 2022-12-05 | 2022-12-01 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2.9717 | -270,964 | -805 | 9,180,710 | ||||
| 2022-12-05 | 2022-12-01 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2.9717 | -63,843 | -190 | 2,163,122 | ||||
| 2022-09-08 | 2022-09-06 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2.4029 | -25,243 | -61 | 9,451,674 | ||||
| 2022-09-08 | 2022-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 2.4029 | -3,934 | -9 | 1,473,100 | ||||
| 2022-09-08 | 2022-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 2.4029 | -2,234 | -5 | 836,499 | ||||
| 2022-09-08 | 2022-09-06 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2.4029 | -5,947 | -14 | 2,226,965 | ||||
| 2022-08-29 | 2022-08-22 | 4 | Guirakhoo Farshad | VAXX | Class A common stock | D | 0.5700 | 2,640 | 2 | 68,645 | ||||
| 2022-08-29 | 2022-08-15 | 4 | Guirakhoo Farshad | VAXX | Class A common stock | D | 0.5700 | 26,005 | 15 | 66,005 | ||||
| 2022-08-29 | 2022-07-29 | 4 | Guirakhoo Farshad | VAXX | Class A common stock | D | 0.5700 | 20,000 | 11 | 40,000 | ||||
| 2022-08-29 | 2022-01-13 | 4 | Guirakhoo Farshad | VAXX | Class A common stock | D | 0.5700 | 10,000 | 6 | 10,000 | ||||
| 2022-08-25 | 2022-08-25 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A common stock | D | 2.3310 | -22,757 | -53 | 9,476,917 | ||||
| 2022-08-25 | 2022-08-25 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A common stock | I | 2.3310 | -3,547 | -8 | 1,477,034 | ||||
| 2022-08-25 | 2022-08-25 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A common stock | I | 2.3310 | -2,014 | -5 | 838,733 | ||||
| 2022-08-25 | 2022-08-25 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A common stock | I | 2.3310 | -5,362 | -12 | 2,232,912 | ||||
| 2022-08-25 | 2022-08-24 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2.3862 | -83,786 | -200 | 9,499,674 | ||||
| 2022-08-25 | 2022-08-24 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 2.3862 | -13,058 | -31 | 1,480,581 | ||||
| 2022-08-25 | 2022-08-24 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 2.3862 | -7,415 | -18 | 840,747 | ||||
| 2022-08-25 | 2022-08-24 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2.3862 | -19,741 | -47 | 2,238,274 | ||||
| 2022-08-25 | 2022-08-23 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2.4466 | -33,785 | -83 | 9,583,460 | ||||
| 2022-08-25 | 2022-08-23 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 2.4466 | -5,265 | -13 | 1,493,639 | ||||
| 2022-08-25 | 2022-08-23 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 2.4466 | -2,990 | -7 | 848,162 | ||||
| 2022-08-25 | 2022-08-23 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2.4466 | -7,960 | -19 | 2,258,015 | ||||
| 2022-06-23 | 2021-11-18 | 4/A | Diamandis Peter | VAXX | Class A common stock | D | 13.0000 | -248 | -3 | 90,499 | ||||
| 2022-06-23 | 2021-11-15 | 4/A | Diamandis Peter | VAXX | Class A common stock | D | 13,824 | 13,824 | ||||||
| 2022-06-23 | 2021-11-15 | 4/A | Diamandis Peter Held by spouse | VAXX | Class A common stock | I | 13,824 | 13,824 | ||||||
| 2022-06-23 | 2022-01-24 | 4/A | Diamandis Peter | VAXX | Class A common stock | D | 8.6000 | -312,659 | -2,689 | 430,604 | ||||
| 2022-06-21 | 2022-06-16 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 1.9929 | 100,000 | 199 | 51,737,344 | ||||
| 2022-06-21 | 2022-06-16 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 1.9929 | 100,000 | 199 | 51,737,344 | ||||
| 2022-06-21 | 2022-06-16 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 1.9929 | 100,000 | 199 | 51,737,344 | ||||
| 2022-06-14 | 2022-06-13 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2.4259 | -92,569 | -225 | 9,617,245 | ||||
| 2022-06-14 | 2022-06-13 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 2.4259 | -14,427 | -35 | 1,498,904 | ||||
| 2022-06-14 | 2022-06-13 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 2.4259 | -8,193 | -20 | 851,152 | ||||
| 2022-06-14 | 2022-06-13 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2.4259 | -21,811 | -53 | 2,265,975 | ||||
| 2022-06-14 | 2022-06-10 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A Common Stock | D | 2.7981 | -28,378 | -79 | 9,709,814 | ||||
| 2022-06-14 | 2022-06-10 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A Common Stock | I | 2.7981 | -4,423 | -12 | 1,513,331 | ||||
| 2022-06-14 | 2022-06-10 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A Common Stock | I | 2.7981 | -2,512 | -7 | 859,345 | ||||
| 2022-06-14 | 2022-06-10 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A Common Stock | I | 2.7981 | -6,687 | -19 | 2,287,786 | ||||
| 2022-06-10 | 2022-06-09 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 2.7193 | 10,978 | 30 | 51,637,344 | ||||
| 2022-06-10 | 2022-06-08 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 2.9534 | 10,000 | 30 | 51,626,366 | ||||
| 2022-06-10 | 2022-06-09 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 2.7193 | 10,978 | 30 | 51,637,344 | ||||
| 2022-06-10 | 2022-06-08 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 2.9534 | 10,000 | 30 | 51,626,366 | ||||
| 2022-06-10 | 2022-06-09 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 2.7193 | 10,978 | 30 | 51,637,344 | ||||
| 2022-06-10 | 2022-06-08 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 2.9534 | 10,000 | 30 | 51,626,366 | ||||
| 2022-05-05 | 2022-05-03 | 4 | Guirakhoo Farshad | VAXX | Stock Option (right to buy) | D | 0.57 | -10,000 | 116,730 | |||||
| 2022-05-05 | 2022-05-03 | 4 | Guirakhoo Farshad | VAXX | Class A common stock | D | 0.5700 | 10,000 | 6 | 10,000 | ||||
| 2022-04-28 | 2022-04-27 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3.5826 | 4,807 | 17 | 51,616,366 | ||||
| 2022-04-28 | 2022-04-26 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3.4503 | 18,105 | 62 | 51,611,559 | ||||
| 2022-04-28 | 2022-04-27 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3.5826 | 4,807 | 17 | 51,616,366 | ||||
| 2022-04-28 | 2022-04-26 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3.4503 | 18,105 | 62 | 51,611,559 | ||||
| 2022-04-28 | 2022-04-27 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 3.5826 | 4,807 | 17 | 51,616,366 | ||||
| 2022-04-28 | 2022-04-26 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 3.4503 | 18,105 | 62 | 51,611,559 | ||||
| 2022-04-27 | 2022-04-25 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3.3681 | 8,038 | 27 | 51,593,454 | ||||
| 2022-04-27 | 2022-04-25 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 3.3681 | 8,038 | 27 | 51,593,454 | ||||
| 2022-04-27 | 2022-04-25 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 3.3681 | 8,038 | 27 | 5,193,454 | ||||
| 2022-04-04 | 2022-03-31 | 4 | Powchik Peter | VAXX | Stock Option (right to buy) | D | 4.30 | 94,186 | 94,186 | |||||
| 2022-04-04 | 3 | Powchik Peter | VAXX | Class A common stock | D | 225,858 | ||||||||
| 2022-03-15 | 2022-03-15 | 4 | Palm Ulo | VAXX | Restricted Stock Units | D | 100,000 | 100,000 | ||||||
| 2022-01-26 | 2022-01-24 | 4 | Diamandis Peter | VAXX | Stock Option (right to buy) | D | 4.12 | -652,764 | 163,191 | |||||
| 2022-01-26 | 2022-01-24 | 4 | Diamandis Peter | VAXX | Class A common stock | D | 4.1192 | 652,764 | 2,689 | 729,687 | ||||
| 2022-01-11 | 2022-01-03 | 4 | Pesile Jason | VAXX | Stock Option (right to buy) | D | 5.96 | 51,225 | 51,225 | |||||
| 2022-01-06 | 2021-12-31 | 4 | Chui James | VAXX | Class A common stock | D | 5.4800 | 6,000 | 33 | 14,000 | ||||
| 2022-01-05 | 2022-01-03 | 4 | HORNIG GEORGE R | VAXX | Stock Option (right to buy) | D | 5.96 | 67,953 | 67,953 | |||||
| 2021-12-14 | 2021-12-10 | 4 | Chui James | VAXX | Class A common stock | D | 7.8900 | 8,000 | 63 | 8,000 | ||||
| 2021-11-18 | 2021-11-16 | 4 | BLATT GREGORY R | VAXX | Class A common stock | D | 76,923 | 76,923 | ||||||
| 2021-11-18 | 2021-11-16 | 4 | BLATT GREGORY R Held by Bald Eagle IV LLC | VAXX | Class A common stock | I | -76,923 | 0 | ||||||
| 2021-11-18 | 2021-11-18 | 4 | Diamandis Peter | VAXX | Class A common stock | D | 76,923 | 76,923 | ||||||
| 2021-11-18 | 2021-11-18 | 4 | Diamandis Peter Held by Bald Eagle IV LLC | VAXX | Class A common stock | I | -76,923 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Diamandis Peter Held by spouse | VAXX | Series A preferred stock | I | -21,511 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Diamandis Peter Held by Bald Eagle IV LLC | VAXX | Class A common stock | I | 76,923 | 76,923 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Diamandis Peter Held by spouse | VAXX | Class A common stock | I | 271,655 | 271,655 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by The Gregory R. Blatt 2020 Annuity Trust III | VAXX | Series B preferred stock | I | -250,000 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by The Gregory R. Blatt 2020 Annuity Trust IX | VAXX | Series A preferred stock | I | -83,329 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by Blatt Family Investments LLC | VAXX | Series A preferred stock | I | -968,636 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by Bald Eagle IV LLC | VAXX | Class A common stock | I | 76,923 | 76,923 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by The Gregory R. Blatt 2020 Annuity Trust III | VAXX | Class A common stock | I | 160,668 | 160,668 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by The Gregory R. Blatt 2020 Annuity Trust IX | VAXX | Class A common stock | I | 53,553 | 53,553 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | BLATT GREGORY R Held by Blatt Family Investments LLC | VAXX | Class A common stock | I | 622,516 | 622,516 | ||||||
| 2021-11-15 | 2021-11-11 | 4 | Guirakhoo Farshad | VAXX | Stock option (right to buy) | D | 13.00 | 41,958 | 41,958 | |||||
| 2021-11-15 | 2021-11-11 | 4 | Paula Molina Rene | VAXX | Stock option (right to buy) | D | 13.00 | 96,153 | 96,153 | |||||
| 2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by United Biomedical Inc., Asia | VAXX | Series A preferred stock | I | -6,554,643 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Series A preferred stock | I | -384,410 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by Blackfoot Healthcare Ventures LLC | VAXX | Series A preferred stock | I | -422,696 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by United Biomedical Inc., Asia | VAXX | Class A common stock | I | 4,212,495 | 4,212,495 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by United Biomedical Inc. | VAXX | Class A common stock | I | 247,050 | 51,585,416 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Reese Lou Held by Blackfoot Healthcare Ventures LLC | VAXX | Class A common stock | I | 271,655 | 271,655 | ||||||
| 2021-11-15 | 2021-11-12 | 4 | Reese Lou | VAXX | Class A common stock | D | 13.8240 | 17,500 | 242 | 17,500 | ||||
| 2021-11-15 | 2021-11-15 | 4 | Palm Ulo Held by spouse | VAXX | Class A common stock | I | 13.0000 | 450 | 6 | 450 | ||||
| 2021-11-15 | 2021-11-11 | 4 | Palm Ulo | VAXX | Stock option (right to buy) | D | 13.00 | 233,100 | 233,100 | |||||
| 2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by United Biomedical Inc., Asia | VAXX | Series A preferred stock | I | -6,554,643 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Series A preferred stock | I | -384,410 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by Blackfoot Healthcare Ventures LLC | VAXX | Series A preferred stock | I | -422,696 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by United Biomedical Inc., Asia | VAXX | Class A common stock | I | 4,212,495 | 4,212,495 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by United Biomedical Inc. | VAXX | Class A common stock | I | 247,050 | 51,585,416 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Hu Mei Mei Held by Blackfoot Healthcare Ventures LLC | VAXX | Class A common stock | I | 271,655 | 271,655 | ||||||
| 2021-11-15 | 2021-11-12 | 4 | Hu Mei Mei Held by spouse | VAXX | Class A common stock | I | 13.8240 | 17,500 | 242 | 17,500 | ||||
| 2021-11-15 | 2021-11-15 | 4 | UNITED BIOMEDICAL INC Held by United Biomedical Inc., Asia | VAXX | Series A preferred stock | I | -6,554,643 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | UNITED BIOMEDICAL INC | VAXX | Series A preferred stock | D | -384,410 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | UNITED BIOMEDICAL INC Held by United Biomedical Inc., Asia | VAXX | Class A common stock | I | 4,212,495 | 4,212,495 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 247,050 | 51,585,416 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP | VAXX | Series A preferred stock | D | -15,152,627 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by Prime Movers Growth Fund 1 LP | VAXX | Series B preferred stock | I | -5,625,000 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Series A preferred stock | I | -2,361,626 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Series A preferred stock | I | -1,341,050 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Series A preferred stock | I | -3,570,201 | 0 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP | VAXX | Class A common stock | D | 9,738,192 | 9,738,192 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by Prime Movers Growth Fund 1 LP | VAXX | Class A common stock | I | 3,615,038 | 3,615,038 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 3 LP | VAXX | Class A common stock | I | 1,517,754 | 1,517,754 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 2 LP | VAXX | Class A common stock | I | 861,857 | 861,857 | ||||||
| 2021-11-15 | 2021-11-15 | 4 | Prime Movers Lab Fund I LP Held by COVAXX PML SPV 1 LP | VAXX | Class A common stock | I | 2,294,473 | 2,294,473 | ||||||
| 2021-11-10 | 3 | UNITED BIOMEDICAL INC | VAXX | Class A common stock | D | 51,338,366 | ||||||||
| 2021-11-10 | 3 | Doran Martin | VAXX | Class A common stock | D | 22,688 | ||||||||
| 2021-11-10 | 3 | Hu Mei Mei Held by United Biomedical Inc. See Note | VAXX | Class A common stock | I | 51,338,366 | ||||||||
| 2021-11-10 | 3 | Hu Mei Mei Held by spouse. See Note | VAXX | Class B common stock | I | 3,955,512 | ||||||||
| 2021-11-10 | 3 | Hu Mei Mei | VAXX | Class B common stock | D | 5,518,961 | ||||||||
| 2021-11-10 | 3 | Diamandis Peter | VAXX | Class B common stock | D | 1,099,915 | ||||||||
| 2021-11-10 | 3 | Reese Lou Held by spouse. See Note | VAXX | Class B common stock | I | 5,518,961 | ||||||||
| 2021-11-10 | 3 | Reese Lou | VAXX | Class B common stock | D | 3,955,511 | ||||||||
| 2021-11-10 | 3 | Reese Lou Held by United Biomedical Inc. See Note | VAXX | Class A common stock | I | 51,338,366 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
